Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac death

[1]  D. Siscovick,et al.  SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. , 2008, Atherosclerosis.

[2]  T. Lehtimäki,et al.  The hepatic lipase gene C‐480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study , 2007, European journal of clinical investigation.

[3]  Mauno Vihinen,et al.  Bioinformatic analysis of protein structure–function relationships: case study of leukocyte elastase (ELA2) missense mutations , 2006, Human mutation.

[4]  Y. Friedlander,et al.  The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients. , 2006, Atherosclerosis.

[5]  M. Hutz,et al.  Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes , 2005, The Pharmacogenomics Journal.

[6]  M. Beylot,et al.  Genes of Cholesterol Metabolism in Human Atheroma: Overexpression of Perilipin and Genes Promoting Cholesterol Storage and Repression of ABCA1 Expression , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Ying Xiao,et al.  The effect of sterol regulatory element-binding protein 2 polymorphism on the serum lipid in northern Chinese subjects Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.M400166-JLR200 , 2005, Journal of Lipid Research.

[8]  R. B. Rawson.  The SREBP pathway — insights from insigs and insects , 2003, Nature Reviews Molecular Cell Biology.

[9]  A. Simon,et al.  Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. , 2003, Atherosclerosis.

[10]  A. Gotto,et al.  Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin , 2002, Journal of Molecular Medicine.

[11]  Y. Friedlander,et al.  Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. , 2002, Atherosclerosis.

[12]  T. Lehtimäki,et al.  Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage‐activating protein polymorphism in healthy young men , 2001, Clinical genetics.

[13]  L. Badimón,et al.  LDL Downregulates CYP51 in Porcine Vascular Endothelial Cells and in the Arterial Wall Through a Sterol Regulatory Element Binding Protein-2–Dependent Mechanism , 2001, Circulation research.

[14]  T. Nakajima,et al.  A common Ile796Val polymorphism of the human SREBP cleavage-activating protein (SCAP) gene , 1999, Journal of Human Genetics.

[15]  T. Nakajima,et al.  Genomic structure and chromosomal mapping of the human sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) gene , 1999, Journal of Human Genetics.

[16]  D T Jones,et al.  Protein secondary structure prediction based on position-specific scoring matrices. , 1999, Journal of molecular biology.

[17]  A. Penttilä,et al.  Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG) , 1999, International Journal of Legal Medicine.

[18]  J. Goldstein,et al.  Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding Proteins* , 1998, The Journal of Biological Chemistry.

[19]  R. Hammer,et al.  Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. , 1998, The Journal of clinical investigation.

[20]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[21]  H. Hobbs,et al.  Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2). , 1997, Genomics.

[22]  Gapped BLAST and PSI-BLAST: A new , 1997 .

[23]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[24]  H. Hobbs,et al.  Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. , 1995, Genomics.

[25]  Burkhard Rost,et al.  PHD - an automatic mail server for protein secondary structure prediction , 1994, Comput. Appl. Biosci..

[26]  M. Brown,et al.  How LDL receptors influence cholesterol and atherosclerosis. , 1984, Scientific American.

[27]  L. Solberg,et al.  Selected methodologic aspects of the International Atherosclerosis Project. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[28]  A. Kagan,et al.  GRADING ATHEROSCLEROSIS IN AORTA AND CORONARY ARTERIES OBTAINED AT AUTOPSY: APPLICATION OF A TESTED METHOD. , 1964, Bulletin of the World Health Organization.